If early reviews are any indication, Snap’s decision to overhaul its messaging app may have backfired with its key teen demographic. And Daily Beast reporter Taylor Lorenz says the changes may not bring in enough “older” users over the age of 25 to make up the difference. “It’s going to have to provide a more compelling use case for them,” she told Cheddar. “Older users are not looking to chat on it. A lot of them use other chat platforms -- Stories has been taken over by Instagram.” Snap has seen backlash from younger users over a complete redesign that was rolled out globally last week. When announcing the new look, CEO Evan Spiegel said the changes separate the platform from the rest of social media and strengthen its relationship with users and the media. Lorenz says that could mean the app becomes more of news destination, but whether the strategy pays off remains to be seen. “They’re hoping to have 10 thousand tiles on the right hand side, so that’s a big opportunity to sell ad inventory. But I think they’re going to need to come up with more unique products, and I think they’re going to have a really hard time competing with Facebook and Instagram who have so much data.” And for those hoping the company will revert to its old design, Lorenz says not to hold their breath. “There is less than a zero chance, I’m so sorry to all the youngsters out there. There’s no going back, unfortunately, for them.” For full interview [click here](https://cheddar.com/videos/snapchats-teen-revolt).

Share:
More In Business
McDonald's Posts Q4 Earnings Miss; McPlant Burger Takes Off
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna's Chief Medical Officer on Omicron Booster Trial, Annual Shots
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
Load More